source link http://communicatebetter.net/?pla=Clomid-Calendar Update: M&A will come back— Pfizer (PFE) buys Anacor (ANAC) for $5.2B. Now you see why inversions are not good for biotech stocks as PFE had to give up reverse merger and go for growth.
http://agahitehran.com/advance-search/?page_id_all=2 Last three posts are still on the mark. The 4% move today in XBI is encouraging ; the 6% move in REGN is also indicative of new money coming in.
Risk remains off.
Back from vacation with a new post on May 22.